A timeline of abortion pill access in 2023

The latest stories trending on MedCity News.

Editor's Pick

Top Story Abortion Pill Access in 2023: A Timeline Mifepristone and misoprostol, two pills that are taken together to terminate a pregnancy, have been approved by the FDA since 2000. But access to these drugs have been in serious jeopardy this year, and a federal judge in Texas recently ruled to suspend the FDA's decadeslong approval of mifepristone. The final outcome for abortion pill access in the U.S. is still unclear among confliction federal rulings — the issue will likely end up in the Supreme Court. Sponsored Content The Vibe at Vive: A Progress Report on Healthcare Transformation Presented by Avaneer Health and MedCity News Ray Jebsen, Avaneer Health Chief Commercial Officer, shared his perspective, gleaned from other industries, as to what changes the healthcare industry needs to make to promote better data fluidity. Watch it here!

Featured News

What Do Payers Need to Help Value-Based Contracting Deals for Novel Therapies Succeed? A panel discussion at the annual Abarca Forward conference in Puerto Rico last month sought to identify some of the innovative financial approaches that can be applied to managing the high price of novel therapies. Conversations also addressed what payers need for these financing models to be sustainable. Hospital M&A Activity Remained Strong in Q1 With 15 Deals Announced Hospital M&A activity remained strong during the first quarter of 2023, according to a new report from Kaufman Hall. Hospitals and health systems announced 15 M&A transactions in the first quarter of 2023, which almost matches the 17 transactions announced in the fourth quarter of 2022. FDA Rejects Eli Lilly Ulcerative Colitis Drug Over Manufacturing Issues Rejection of Eli Lilly's mirikizumab means that two of the four drugs the pharma giant identified as revenue growth drivers for 2023 have failed to pass the regulatory bar. One of those drugs has been approved while the fourth drug still awaits an FDA decision. Blue Cross Blue Shield Association Partners With Cyversity To Create Diverse Cybersecurity Workforce The Blue Cross Blue Shield Association announced it is partnering with Cyversity, a nonprofit working to create a diverse and inclusive workforce in the cybersecurity field. The two organizations are forming a training and mentorship program available to Blue Cross and Blue Shield companies and Cyversity members. Papa Expands Care Navigation Platform After Limited Rollout Papa's Social Care Navigation offering provides users with a team of social care navigators, including social workers, registered nurses, case managers and dieticians. This team can help with social issues the patient may be experiencing, including housing, paying for groceries and overdue health screenings. After only offering the program to a select group of health plan clients last year, Social Care Navigation is now available to all of Papa's payer customers. Alentis Therapeutics Lands $105M for Clinical Trials in Fibrosis and Cancer Three months after Alentis Therapeutics' lead program posted positive Phase 1 data, the biotech has raised cash to advance that program to mid-stage testing in fibrosis. The Series C financing will also support a cancer drug candidate ready to start human testing. Payer Negotiations Are Getting Ugly As margins at health systems continue to contract, and insurance company profits continue to surge, contract negotiations are becoming increasingly contentious. With billions of dollars potentially at stake, you need to be prepared and aligned well in advance. A New Alzheimer's Drug is Finally Here – Our Healthcare System is Far from Ready The new year always brings hope, but this January that hope was palpable for the […] Why Virtual Reality and Podcasts Will Revolutionize the Healthcare Marketing Industry Virtual reality and podcasts are two innovative tools that can help captivate your audience and differentiate your healthcare brand. By utilizing these cutting-edge technologies, you can stay ahead of the competition and create more engaging marketing campaigns.

Resources

MedCity Pivot: Blue Shield of California CEO Says Value of HealthTech Has Been Mixed So Far Paul Markovich believes in the value of health tech in managing both chronic diseases and in general health and wellness. In this episode, he talks about the company's Wellvolution platform and the digital tools that are offered there to members, now even to those on Medicaid. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe